Table.
Baseline characteristics of patients included in the study.
| Characteristics | Hemophilia A (n = 406) | Hemophilia B (n = 40) | Total group (n = 446) |
|---|---|---|---|
| Age (y), median (range) | 46 (0.4-86) | 40 (13-73) | 44 (0.4-86) |
| Age categories (%) | |||
| Children, 0-17 y | 48 (12) | 1 (3) | 49 (11) |
| Adults, ≥18 y | 358 (88) | 39 (98) | 397 (89) |
| Severity of hemophilia (%) | |||
| Severe | 67 (17) | 5 (13) | 72 (16) |
| Moderate | 82 (20) | 10 (25) | 92 (21) |
| Mild | 257 (63) | 25 (63) | 282 (63) |
| Patients using prophylaxis (%) | 56 (14) | 4 (10) | 60 (13) |
| Inhibitor status (%) | |||
| Never | 363 (89) | 40 (100) | 403 (90) |
| Past | 33 (8) | 33 (7) | |
| Current | 9 (2) | 9 (2) | |
| Unknown | 1 | 1 | |
| Concomitant coagulation disorder (%) | |||
| Von Willebrand disease | 8 (2)a | 0 | 8 (2)a |
| Thrombocytopathy | 1b | 0 | 1b |
| Clotting factor deficiency | 2c | 0 | 2c |
a
Data were missing for 1 patient.
b
Data were missing for 5 patients.
c
Data were missing for 2 patients.